[AP] - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.
[AP] - Abbott Laboratories said Wednesday the Food and Drug Administration cleared the company's new hepatitis B test. The FDA approved the Abbott RealTime HBV test, which measures the amount of hepatitis B virus in a patient's blood.
[PR Newswire] - Abbott announced today it has received approval from the U.S. Food and Drug Administration to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus in a patient's blood.
[AP] - Early retiree Richard Rouse told federal officials Tuesday he would like to know that his former employers' health plan for retirees is stable and won't be raising his $500 monthly premiums.
-- Abbott (NYSE: ABT) announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis... (Source: Press Release)
-- 09/01/10 -- www.stockcall.com/ offers investors comprehensive research on the major drug manufacturers industry and has completed analytical research on GlaxoSmithKline (NYSE: GSK) and Abbott Laboratories... (Source: Press Release)
Abbott Laboratories (ABT) has recalled bottles of two contact lens solutions in parts of Europe and the Middle East because of poor-fitting caps that could compromise the products' sterility. The recall... (Source: Dow Jones Newswires)
-- Abbott (NYSE: ABT) will present at the Morgan Stanley Global Healthcare Unplugged Conference on Monday, Sept. 13, 2010. Thomas C. Freyman, executive vice president, finance and chief financial officer,... (Source: Press Release)
